Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.895
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (5.747%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.895
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Results 2020

26 Nov 2020 10:43

RNS Number : 6289G
JPEL Private Equity Limited
26 November 2020
 

JPEL Private Equity Limited

Ground Floor

Cambridge House

Le Truchot, St Peter Port

Guernsey, GY1 1WD

www.jpelonline.com

 

 

JPEL ANNOUNCES RESULTS OF AGM

 

 

* * *

 

GUERNSEY, 26 NOVEMBER 2020

 

JPEL Private Equity Limited (the "Company") announces that at the Annual General Meeting ("AGM") of the Company held on 25 November 2020, all resolutions put to shareholders at the AGM were duly passed.

 

SUMMARY OF RESOLUTIONS PROPOSED AT AGM

 

SUMMARY OF RESOLUTIONS TO BE PROPOSED

The following summarises all of the resolutions the Company sought approval for at the AGM.

 

Special Resolutions

1. To renew the Company's authority to make purchases of up to 15 per cent. of each class of its own issued Shares pursuant to any proposed Tender Offer.

2. To renew the Company's general authority to make market purchases of up to 14.99 per cent. of each class of its own issued Shares.

 

Ordinary Resolutions

3. To approve and adopt the Annual Report and Financial Statements of the Company for the year ended 30 June 2020.

4. To re-elect PricewaterhouseCoopers CI LLP as Auditors to the Company.

5. To re-authorise the Directors to determine the Auditors' remuneration.

6. To re-authorise and agree the remuneration of the Directors in accordance with the Articles of Incorporation.

7. To re-elect Christopher P. Spencer as a non-executive, independent director of the Company, who retires by rotation.

8. To re-elect John Loudon as a non-executive, independent director of the Company, who retires by rotation.

9. To re-elect Anthony (Tony) Dalwood as a non-executive, independent director of the Company, who retires by rotation.

10. To re-elect Sean Hurst as a non-executive, independent director of the Company, who retires by rotation.

 

 

 

Below, please find a summary of all votes received for JPEL's AGM:

 

In Favour

Discretion

Against

Withheld

Resolution

Votes

%age

Items

Votes

%age

Items

Votes

%age

Items

Votes

Items

1

87,106,576

100

15

0

0

0

0

0

0

0

0

2

87,106,576

100

15

0

0

0

0

0

0

0

0

3

87,106,576

100

15

0

0

0

0

0

0

0

0

4

87,106,576

100

15

0

0

0

0

0

0

0

0

5

87,106,576

100

15

0

0

0

0

0

0

0

0

6

87,106,576

100

15

0

0

0

0

0

0

0

0

7

76,819,352

88.19

14

0

0

0

10,287,224

11.81

1

0

0

8

59,440,155

68.24

14

0

0

0

27,666,421

31.76

3

0

0

9

87,106,576

100

15

0

0

0

0

0

0

0

0

10

76,819,352

100

14

0

0

0

0

0

0

10,287,224

1

 

 

The Board has considered the results of the AGM today and notes the level of votes cast against resolution 8 (the re-election of John Loudon) by a small number of shareholders.

 

We have engaged with our major shareholders ahead of the vote and understand their views on these matters and the differing philosophies they apply.

 

Following the outcome of today's vote, we will contact shareholders to discuss these matters again and will keep best practice in these areas under review. In accordance with the provisions of the 2019 AIC Code of Corporate Governance, we shall provide an update on this engagement process over the coming months.

 

 

* * *

 

 

 

About JPEL Private Equity Limited

JPEL Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well-diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market.

 

 

 

 

 

ENQUIRIES:

 

FCF JPEL Management LLC

JPELClientService@fortress.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBGBDBGSDDGGL
Date   Source Headline
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.